Guided Therapeutics (GTHP) Invested Capital (2011 - 2024)

Guided Therapeutics has reported Invested Capital for 13 years, with the latest figure at $1.1 million in Q3 2024.

• Quarterly Invested Capital changed N/A year-over-year to $1.1 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $1.1 million (changed 0.0% YoY) and the FY2022 annual result came in at $17000.0, down 80.68% from the prior year.
• Invested Capital steadied at $1.1 million in Q3 2024 per GTHP's latest filing, from $1.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $1.1 million in Q2 2024 and troughed at $17000.0 in Q4 2022.
• A 4-year average of $330454.5 and a median of $88000.0 in 2021 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 2661.11% in 2022, down 84.74% in 2022.
• Over 4 years, Invested Capital stood at $328000.0 in 2020, then sank by 73.17% to $88000.0 in 2021, then tumbled by 80.68% to $17000.0 in 2022, then surged by 6547.06% to $1.1 million in 2024.
• According to Business Quant data, Invested Capital over the past three periods registered $1.1 million, $1.1 million, and $17000.0 for Q3 2024, Q2 2024, and Q4 2022 respectively.